Telcon RF Pharmaceutical Inc
KOSDAQ:200230
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MSP Recovery Inc
NASDAQ:LIFW
|
US |
|
Nongfu Spring Co Ltd
HKEX:9633
|
CN |
|
Global Lighting Technologies Inc
TWSE:4935
|
KY |
|
I
|
Impact Silver Corp
OTC:ISVLF
|
CA |
|
C
|
CTC Bio Inc
KOSDAQ:060590
|
KR |
|
Hyosung ITX Co Ltd
KRX:094280
|
KR |
|
G
|
Great Boulder Resources Ltd
ASX:GBR
|
AU |
|
Royal Mail PLC
LSE:RMG
|
UK |
Telcon RF Pharmaceutical Inc
Total Equity
Telcon RF Pharmaceutical Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Telcon RF Pharmaceutical Inc
KOSDAQ:200230
|
Total Equity
₩101.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
9%
|
|
|
D
|
DreamTech Co Ltd
KRX:192650
|
Total Equity
₩366.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
K
|
KH Electron Co Ltd
KOSDAQ:111870
|
Total Equity
₩88.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
|
|
P
|
Pavonine Co Ltd
KOSDAQ:177830
|
Total Equity
₩76.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
P
|
PJ Electronics Co Ltd
KOSDAQ:006140
|
Total Equity
₩135.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Telcon RF Pharmaceutical Inc
Glance View
TELCON RF PHARMACEUTICAL.Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2014-11-24. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.
See Also
What is Telcon RF Pharmaceutical Inc's Total Equity?
Total Equity
101.7B
KRW
Based on the financial report for Sep 30, 2025, Telcon RF Pharmaceutical Inc's Total Equity amounts to 101.7B KRW.
What is Telcon RF Pharmaceutical Inc's Total Equity growth rate?
Total Equity CAGR 10Y
9%
Over the last year, the Total Equity growth was 7%. The average annual Total Equity growth rates for Telcon RF Pharmaceutical Inc have been 6% over the past three years , -3% over the past five years , and 9% over the past ten years .
